White Papers / Articles

NSF International has developed multiple white papers and byline articles that provide advice and insight on a variety of public health and environmental issues.  Learn more by reading these articles.

Latest News

  • Opinion Paper: Industry’s Role in Taking Sustainability to Scale

      • 1 week ago

    The consumer goods industry has made great progress and investment in sustainability initiatives, but relative...

    View PDF


  • White Paper: Data Integrity - A Closer Look

      • 2 weeks ago

    NSF conducted extensive research into warning letters issued from 2005 to 2017 for data integrity...

    View PDF


  • White Paper: Hierarchy for CAPA Effectiveness

      • 2 weeks ago

    Have you ever reviewed an investigation report and wondered whether the proposed corrective and preventive...

    View PDF


  • White Paper: Review of EU ATMP GMP Guidance

      • 2 weeks ago

    In this white paper, Robert Smith provides a deep review of the EU advanced therapy...

    View PDF


  • White Paper: The Future of the Pharmaceutical Industry

      • 2 weeks ago

    In this white paper, Martin Lush explains his view of the future of the pharmaceutical...

    View PDF


  • White Paper: U.S. Medical Device Reporting Code Transition

      • 2 weeks ago

    This white paper outlines current coding requirements for reporting adverse medical device events to the...

    View PDF


  • Research Reinforces Need for Dietary Supplement GMPS, Product Testing and Certification

      • 2 months ago

    Recent research conducted by scientists from NSF International, Harvard Medical School, the United States Department...

    View PDF


  • White Paper: Hybrids: We’re All A Bit Mixed Up

      • 3 months ago

    Hybrids: a topic important in the food and dietary supplement industries- and ultimately to consumers....

    Read More


  • White Paper: Quantifying Sustainability Impacts and Setting Successful Sustainability Goals

      • 4 months ago

    Customers and investors are demanding stronger sustainability commitments from companies they work with. The question...

    Read More


  • White Paper: 2017 – A Year in Review of Medical Devices

      • 4 months ago

    Regulatory affairs professionals work in a dynamic environment and 2017 was no exception. While the...

    View PDF


  • White Paper: What Does Poor Quality Cost?

      • 4 months ago

    The cost of quality. A simple statement and yet few companies in the pharmaceutical manufacturing...

    View PDF


  • White Paper: Aging Facilities

      • 4 months ago

    Aging facilities is a trendy catchphrase that has taken hold in the biopharmaceutical industry.  This...

    View PDF


  • White Paper: Risk Assessment: A Closer Look

      • 4 months ago

    NSF International’s Andy Barnett takes a deeper look into ICH Q9, Quality Risk Management, with...

    View PDF


  • White Paper: Is Fear of Risk Your Biggest Risk?

      • 4 months ago

    In this white paper, NSF International's Martin Lush gives his insights into the pharmaceutical industry's...

    View PDF


  • White Paper: Brexit Implications for UK Pharmaceutical Administration

      • 5 months ago

    NSF International's Pete Gough provides some answers on what the historic vote to leave the...

    View PDF


  • Page 1 2 3 Next › Last ›

close